Roca Oporto FJ - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD.

Roca Oporto FJ, Andrades Gómez C, Montilla Cosano G, Aguilera AL, Rocha JL. Roca Oporto FJ, et al. Kidney Int Rep. 2024 Jan 12;9(4):1031-1039. doi: 10.1016/j.ekir.2024.01.020. eCollection 2024 Apr. Kidney Int Rep. 2024. PMID: 38765583 Free PMC article.

Raynaud's phenomenon triggered by the vasopressin V₂ receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.

Roca Oporto FJ, Rocha JL. Roca Oporto FJ, et al. Clin Kidney J. 2021 Dec 9;15(4):827-828. doi: 10.1093/ckj/sfab260. eCollection 2022 Apr. Clin Kidney J. 2021. PMID: 35371438 Free PMC article. No abstract available.

[Use of 48-hour ABPM in specialist care. Experience in our centre].

Roca Oporto FJ, Pérez García M, Martín Gómez MA. Roca Oporto FJ, et al. Hipertens Riesgo Vasc. 2022 Jan-Mar;39(1):8-13. doi: 10.1016/j.hipert.2021.09.001. Epub 2021 Oct 13. Hipertens Riesgo Vasc. 2022. PMID: 34656460 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters